News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
697,777 Results
Type
Article (40222)
Company Profile (253)
Press Release (657302)
Section
Business (204881)
Career Advice (2023)
Deals (35471)
Drug Delivery (94)
Drug Development (81144)
Employer Resources (170)
FDA (16188)
Job Trends (14902)
News (346101)
Policy (32592)
Tag
2024 BioCapital Digital (7)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (6)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2592)
Academic (1)
Accelerated approval (2)
Adcomms (20)
Allergies (78)
Alliances (49657)
ALS (79)
Alzheimer's disease (1335)
Antibody-drug conjugate (ADC) (99)
Approvals (16173)
Artificial intelligence (217)
Autoimmune disease (11)
Automation (14)
Bankruptcy (361)
Best Places to Work (11666)
BIOSECURE Act (18)
Biosimilars (95)
Biotechnology (180)
Bladder cancer (50)
Brain cancer (24)
Breast cancer (238)
Cancer (1835)
Cardiovascular disease (139)
Career advice (1684)
Career pathing (29)
CAR-T (133)
Cell therapy (380)
Cervical cancer (14)
Clinical research (65593)
Collaboration (721)
Compensation (419)
Complete response letters (18)
COVID-19 (2592)
CRISPR (34)
C-suite (192)
Cystic fibrosis (97)
Data (1777)
Decentralized trials (2)
Denatured (15)
Depression (36)
Diabetes (227)
Diagnostics (6338)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (108)
Drug pricing (94)
Drug shortages (25)
Duchenne muscular dystrophy (70)
Earnings (85958)
Editorial (30)
Employer branding (21)
Employer resources (146)
Events (111729)
Executive appointments (609)
FDA (17187)
Featured Employer (49)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (653)
Gene editing (92)
Generative AI (18)
Gene therapy (265)
GLP-1 (666)
Government (4395)
Grass and pollen (4)
Guidances (47)
Healthcare (18827)
Huntington's disease (22)
IgA nephropathy (20)
Immunology and inflammation (92)
Indications (24)
Infectious disease (2714)
Inflammatory bowel disease (128)
Inflation Reduction Act (8)
Influenza (44)
Intellectual property (73)
Interviews (314)
IPO (16501)
IRA (40)
Job creations (3665)
Job search strategy (1434)
Kidney cancer (9)
Labor market (30)
Layoffs (445)
Leadership (15)
Legal (7915)
Liver cancer (71)
Lung cancer (267)
Lymphoma (124)
Machine learning (2)
Management (58)
Manufacturing (255)
MASH (58)
Medical device (13330)
Medtech (13335)
Mergers & acquisitions (19396)
Metabolic disorders (595)
Multiple sclerosis (62)
NASH (16)
Neurodegenerative disease (71)
Neuropsychiatric disorders (23)
Neuroscience (1780)
NextGen: Class of 2025 (6531)
Non-profit (4505)
Northern California (2275)
Now hiring (36)
Obesity (328)
Opinion (197)
Ovarian cancer (61)
Pain (71)
Pancreatic cancer (72)
Parkinson's disease (125)
Partnered (17)
Patents (186)
Patient recruitment (86)
Peanut (45)
People (57283)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20458)
Phase II (28884)
Phase III (21502)
Pipeline (853)
Podcasts (41)
Policy (104)
Postmarket research (2568)
Preclinical (8631)
Press Release (68)
Prostate cancer (86)
Psychedelics (30)
Radiopharmaceuticals (243)
Rare diseases (343)
Real estate (5960)
Recruiting (65)
Regulatory (22098)
Reports (43)
Research institute (2358)
Resumes & cover letters (351)
Rett syndrome (3)
RNA editing (2)
RSV (37)
Schizophrenia (61)
Series A (116)
Series B (70)
Service/supplier (11)
Sickle cell disease (49)
Southern California (1966)
Special edition (14)
Sponsored (28)
Startups (3596)
State (2)
Stomach cancer (12)
Supply chain (58)
The Weekly (25)
United States (20040)
Vaccines (642)
Venture capitalists (35)
Webinars (12)
Weight loss (220)
Women's health (31)
Worklife (14)
Date
Today (125)
Last 7 days (592)
Last 30 days (2943)
Last 365 days (34034)
2025 (6466)
2024 (35273)
2023 (40148)
2022 (51254)
2021 (55816)
2020 (54213)
2019 (46703)
2018 (35181)
2017 (32288)
2016 (31678)
2015 (37795)
2014 (31496)
2013 (26573)
2012 (28774)
2011 (29459)
2010 (27561)
Location
Africa (721)
Alabama (48)
Alaska (7)
Arizona (215)
Arkansas (12)
Asia (37860)
Australia (6184)
California (5208)
Canada (1802)
China (425)
Colorado (237)
Connecticut (252)
Delaware (119)
Europe (81143)
Florida (773)
Georgia (182)
Idaho (57)
Illinois (468)
India (22)
Indiana (282)
Iowa (7)
Japan (131)
Kansas (99)
Kentucky (23)
Louisiana (7)
Maine (60)
Maryland (799)
Massachusetts (3939)
Michigan (206)
Minnesota (353)
Mississippi (2)
Missouri (73)
Montana (27)
Nebraska (25)
Nevada (54)
New Hampshire (62)
New Jersey (1481)
New Mexico (28)
New York (1490)
North Carolina (885)
North Dakota (7)
Northern California (2275)
Ohio (181)
Oklahoma (13)
Oregon (33)
Pennsylvania (1183)
Puerto Rico (7)
Rhode Island (24)
South America (1102)
South Carolina (16)
South Dakota (1)
Southern California (1966)
Tennessee (89)
Texas (768)
Utah (160)
Virginia (123)
Washington D.C. (56)
Washington State (495)
West Virginia (3)
Wisconsin (47)
697,777 Results for "saladax biomedical inc sbi".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
Health Canada Approves Saladax’s 5-Fluorouracil Chemotherapy Therapeutic Drug Monitoring (TDM) Test
Saladax Biomedical, Inc. is pleased to announce that Health Canada has approved Saladax’s 5-Fluorouracil Assay for sale in Canada in a rapid six days.
May 14, 2024
·
2 min read
Press Releases
electroCore, Inc. Announces Agreement with Spark Biomedical Inc. to Distribute Sparrow Ascent for Opioid Withdrawal
February 27, 2025
·
4 min read
Press Releases
Impact BioMedical Inc. to Present at The Microcap Conference
January 23, 2025
·
1 min read
Press Releases
Stream Biomedical, Inc. Announces Acceptance of Abstract for Presentation at Annual Meeting of the American Society of Neurotherapeutics (ASENT) Conference 2025
March 5, 2025
·
2 min read
Deals
Saladax Biomedical, Inc. Acquires Intellectual Property Portfolio for Antipsychotic Drug Tests
Saladax Biomedical, Inc. is pleased to announce that it has acquired a patent portfolio for antipsychotic drug testing from Janssen Pharmaceutica NV.
April 5, 2022
·
2 min read
Business
Saladax Biomedical, Inc. Announces Global Distribution Agreement With Beckman Coulter, Inc. for Antipsychotic Drug Tests
Saladax Biomedical, Inc. (Saladax) is pleased to announce the signing of a global distribution agreement with Beckman Coulter, Inc. to distribute the MyCare™ Psychiatry Laboratory Assays. The MyCare™ Psychiatry Laboratory Assays measure drug levels of the antipsychotic drugs prescribed to treat patients with serious mental illness (SMI), such as such as Schizophrenia and Bipolar Disorder.
March 15, 2022
·
4 min read
Drug Development
Skye Bioscience Treats First Patient in Glaucoma Phase 2 Study of SBI-100 Ophthalmic Emulsion
Skye Bioscience, Inc. has treated the first patient in its Phase 2 clinical trial evaluating SBI-100 Ophthalmic Emulsion’s (“OE”) ability to lower intraocular pressure (“IOP”), safety and relevant biomarkers, in patients with primary open-angle glaucoma (“POAG”) or ocular hypertension (“OHT”).
November 28, 2023
·
6 min read
Press Releases
First Ascent Biomedical Secures $6 Million Investment from Vidal Duart Enterprises, Inc. to Revolutionize Cancer Treatment
January 13, 2025
·
4 min read
Business
Saladax Biomedical and HLS Therapeutics Strengthen Partnership With an Exclusive Distribution Agreement for Canada
Saladax Biomedical, Inc (Saladax) is pleased to announce an exclusive distribution agreement with HLS Therapeutics Inc. (“HLS”) (TSX:HLS) to distribute five MyCare™ Psychiatry Laboratory Assays used to measure the six most commonly prescribed antipsychotic drugs in Canada.
November 18, 2021
·
3 min read
Press Releases
Lifecore Biomedical to Participate in Upcoming Investor and Industry Conferences
February 27, 2025
·
2 min read
1 of 69,778
Next